Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer

Affiliations

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
² Department of Biostatistics, Harvard University, Boston, Massachusetts.

Comment

Hajime Uno et al. JAMA. 2018.

. 2018 Jan 16;319(3):306.

doi: 10.1001/jama.2017.18312.

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
² Department of Biostatistics, Harvard University, Boston, Massachusetts.

No abstract available

Comment in

Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer-Reply.
Ballman KV, McCall LM, Giuliano AE. Ballman KV, et al. JAMA. 2018 Jan 16;319(3):306-307. doi: 10.1001/jama.2017.18318. JAMA. 2018. PMID: 29340672 No abstract available.

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M. Giuliano AE, et al. JAMA. 2017 Sep 12;318(10):918-926. doi: 10.1001/jama.2017.11470. JAMA. 2017. PMID: 28898379 Free PMC article. Clinical Trial.